This site is best viewed at 1280 x 1024 resolution.Close

Clinically Proven to Work

BELVIQ® can help you lose weight and improve certain health risk factors — In FDA clinical trials, people who added BELVIQ® to diet and exercise were able to lose weight and improve health risk factors, such as high blood pressure, high blood sugar, and high cholesterol levels. BELVIQ® was tested in two major clinical studies, one lasting a year (4,008 people) and one lasting 2 years (3,182 people).*

The combined results of these two studies showed that:

  • Almost half of people (47.1%) taking BELVIQ® lost 5% or more of their body weight after 1 year of treatment, compared with those using diet and exercise alone (22.6%)
  • Some (22.4%) lost as much as 10% of their body weight after 1 year of treatment, compared with those using diet and exercise alone (8.7%)

People taking BELVIQ with diet and exercise had significant improvements in their blood pressure and cholesterol levels, compared to those using diet and exercise alone. It is not known if BELVIQ changes your risk of heart problems, stroke, or death due to heart problems or stroke.

BELVIQ® can help you manage your weight loss — In a major clinical trial, people taking BELVIQ were able to lose weight and maintain weight loss up to 2 years. In the 2-year study, almost half of people who completed the first year continued on in year 2. All people regained weight but remained below their starting weight.

BELVIQ® helps overweight people with type 2 diabetes lose weight — BELVIQ was also tested in a study involving 604* overweight men and women with type 2 diabetes. Results showed that more than a third of people taking BELVIQ with diet and exercise (37.5%) lost 5% or more of their body weight, compared with those using diet and exercise alone (16.1%). In the same study, the BELVIQ group showed significant improvements in blood sugar levels, compared with those using diet and exercise alone.

*Nearly half of all participants completed the studies in overweight patients without diabetes; nearly two-thirds of the participants completed the study in overweight patients with diabetes.

Restrictions and Conditions of Use:

Savings Card

  • Good toward the purchase of prescriptions for BELVIQ® (lorcaserin HCl) CIV for up to 12 uses per year. Limited to 1 prescription per patient for any 30-day period. Eisai Inc. will contribute no more than $200 per prescription. Save this card to reuse each month up to the expiration date. No substitutions permitted.
  • Must be 18 years of age or older.
  • Not available to individuals eligible for federal healthcare programs that cover prescription drugs, including Medicare, Medicaid, MediGap, VA, DOD, TRICARE, or any similar state or federal healthcare programs.
  • Not valid for prescriptions for BELVIQ reimbursed in full by any third-party payer.
  • Patients and pharmacies are responsible for disclosing to insurance carriers the redemption and value of the card and complying with any other conditions imposed by insurance carriers or third-party payers.
  • May not be combined with any other coupon, discount, prescription savings card, free trial, or other offer.
  • The value of this card is not contingent on any prior or future purchases. The card is solely intended to provide savings on any purchase of BELVIQ. Use of the card for any 1 purchase does not obligate the patient to make future purchases of BELVIQ or any other product.
  • Void outside the USA and where prohibited by law.
  • This card expires 01/31/2017.
  • Federal law prohibits the selling, purchasing, trading, or counterfeiting of this savings card; such activities may result in imprisonment of 10 years, fines of $250,000, or both.
  • Eisai Inc. reserves the right to rescind, revoke, or amend this offer without notice at any time.
  • Other restrictions apply.

Terms of Information Use

Please be advised that the personal information you provide will be used to satisfy your request to receive or activate a trial voucher or savings card. The marketer of BELVIQ, Eisai Inc. (“Eisai” or “we”), operates this website and our Privacy Policy will govern the collection, use, disclosure and retention of the information you provide here. Please do not submit any personal information unless you have read and agree with the terms of that Privacy Policy. Consistent with the Privacy Policy, we and our service providers may use the personal information you provide to contact you and send you communications, including about products or services that may interest you. At any time, you may request to be removed from the list to receive such communications by contacting Eisai Corporate Communications at: By clicking “submit” below, you agree that you have read, understand, and agree to these conditions.

You are leaving

Eisai Inc. does not endorse and is not responsible for the content included on the site you are about to enter. Click the "Continue" button to proceed.

Cancel or close this window to return to